Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by Matt Sabatello and Rich Johannesen, Matt Sabatello, and Rich Johannesen. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Matt Sabatello and Rich Johannesen, Matt Sabatello, and Rich Johannesen or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Episode 487: LIVE from ILADS: Dr. Jyotsna Shah - Advancing Lyme Disease Testing with IGeneX

15:19
 
Share
 

Manage episode 475787153 series 2540476
Content provided by Matt Sabatello and Rich Johannesen, Matt Sabatello, and Rich Johannesen. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Matt Sabatello and Rich Johannesen, Matt Sabatello, and Rich Johannesen or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

Dr. Jyotsna Shah, PhD, is the President and Laboratory Director of IGeneX, a leading Lyme disease testing laboratory. With over 40 years of research experience in immunology, molecular biology, and microbiology, she holds more than 20 patents. Dr. Shah’s journey in Lyme disease research began at Harvard University, and she has since played a pivotal role in advancing diagnostic tools for tick-borne diseases. Under her leadership, IGeneX has developed innovative testing methods, including the first Fluorescent In Situ Hybridization (FISH) test for Babesia.

Key Takeaways:

  • IGeneX is considered the premier Lyme disease testing lab by the patient community due to the positive outcomes patients experience.
  • Dr. Shah's early exposure to Lyme disease research at Harvard University and a personal connection through a colleague led her to focus her career on this field.
  • The development of the Fluorescence In Situ Hybridization (FISH) technique was a crucial factor in Dr. Shah's decision to pursue Lyme disease research.
  • Navigating the clinical lab management aspect of IGeneX was an unexpected challenge, but Dr. Shah worked closely with state inspectors to ensure the lab's safety and trustworthiness.
  • Obtaining insurance coverage for IGeneX's specialized tests has been an ongoing challenge, but the lab's focus on patient outcomes has earned it the trust of the Lyme disease community.

Resources & Links:

  continue reading

516 episodes

Artwork
iconShare
 
Manage episode 475787153 series 2540476
Content provided by Matt Sabatello and Rich Johannesen, Matt Sabatello, and Rich Johannesen. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Matt Sabatello and Rich Johannesen, Matt Sabatello, and Rich Johannesen or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

Dr. Jyotsna Shah, PhD, is the President and Laboratory Director of IGeneX, a leading Lyme disease testing laboratory. With over 40 years of research experience in immunology, molecular biology, and microbiology, she holds more than 20 patents. Dr. Shah’s journey in Lyme disease research began at Harvard University, and she has since played a pivotal role in advancing diagnostic tools for tick-borne diseases. Under her leadership, IGeneX has developed innovative testing methods, including the first Fluorescent In Situ Hybridization (FISH) test for Babesia.

Key Takeaways:

  • IGeneX is considered the premier Lyme disease testing lab by the patient community due to the positive outcomes patients experience.
  • Dr. Shah's early exposure to Lyme disease research at Harvard University and a personal connection through a colleague led her to focus her career on this field.
  • The development of the Fluorescence In Situ Hybridization (FISH) technique was a crucial factor in Dr. Shah's decision to pursue Lyme disease research.
  • Navigating the clinical lab management aspect of IGeneX was an unexpected challenge, but Dr. Shah worked closely with state inspectors to ensure the lab's safety and trustworthiness.
  • Obtaining insurance coverage for IGeneX's specialized tests has been an ongoing challenge, but the lab's focus on patient outcomes has earned it the trust of the Lyme disease community.

Resources & Links:

  continue reading

516 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Listen to this show while you explore
Play